Remove 2014 Remove Drug Development Remove Patient Experience
article thumbnail

Let’s Save the Date and Make Patient Engagement Official in 2022

Society for Participatory Medicine

However, we are still missing the mark with patient involvement to make durable healthcare change towards a culture of patient centricity. My mission of advocacy was widened and deepened upon my stage IV colorectal cancer diagnosis in 2014 when I shared my expertise with others fighting for scans and treatments.

BioTech 97
article thumbnail

AngelEye Health Announces Series B Funding to Support Company’s Rapid Growth

Healthcare IT Today

The new financing will be used to accelerate the organization’s rapid expansion, including growing its team of talent and expanding its product research and development function. Within Life Sciences, the firm focuses on MedTech, Diagnostics, and Opportunistic Drug Development. For more information, visit www.mtngp.com.